rs730880505
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The ENST00000307102.10(MAP2K1):c.568+1G>A variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,458,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000307102.10 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP2K1 | NM_002755.4 | c.568+1G>A | splice_donor_variant | ENST00000307102.10 | NP_002746.1 | |||
MAP2K1 | NM_001411065.1 | c.424+1G>A | splice_donor_variant | NP_001397994.1 | ||||
MAP2K1 | XM_011521783.4 | c.502+1G>A | splice_donor_variant | XP_011520085.1 | ||||
MAP2K1 | XM_017022411.3 | c.490+1G>A | splice_donor_variant | XP_016877900.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP2K1 | ENST00000307102.10 | c.568+1G>A | splice_donor_variant | 1 | NM_002755.4 | ENSP00000302486 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251432Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135882
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1458804Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 725942
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 22, 2015 | The c.568+1G>A variant in MAP2K1 has not been previously reported in individuals with HCM or a RASopathy, and was absent from large population studies. This var iant occurs in the invariant region (+/- 1,2) of the splice consensus sequence a nd is predicted to cause altered splicing leading to an abnormal or absent prote in. To date, all disease-causing variants in MAP2K1 are activating mutations, a nd splice variants are not a known mechanism of disease in individuals with a RA Sopathy. In summary, the clinical significance of the c.568+1G>A variant is unc ertain since it is unclear what impact this variant would have on the protein. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 25, 2023 | Canonical splice site variant in a gene or region of a gene for which loss of function is not a well-established mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at